A Protocol to Acquire the Degenerative Tenocyte from Humans

Area of Science:

• Biomedical Science
• Cell Biology
• Orthopedics

Background:

• Tendinopathy is a growing concern globally, characterized by tendon degeneration.
• Current understanding of tendinopathy pathogenesis is limited, and treatments are primarily symptomatic.
• Research on novel therapies often relies on animal models or healthy human cells, lacking data from pathological human cells.

Purpose of the Study:

• To establish a standardized protocol for acquiring human degenerative tenocytes.
• To provide a reliable source of pathological tenocytes for tendinopathy research.

Main Methods:

• Harvesting tendon tissue from patients with lateral epicondylitis during surgery.
• Biopsy of the extensor carpi radialis brevis tendon exhibiting structural changes.
• Histological and immunocytochemical analysis of harvested tissue and cultured cells.
• Comparative analysis of degenerative tenocytes versus healthy controls using proliferation assays and qRT-PCR.

Main Results:

• Harvested tendons displayed visual characteristics of tendinopathy (dull, gray, friable, edematous).
• Histological analysis confirmed features of angiofibroblastic dysplasia/hyperplasia.
• Immunocytochemistry verified cultured cells as tenocytes expressing Mohawk and Tenomodulin.
• Degenerative tenocytes exhibited a higher proliferation rate compared to healthy controls.

Conclusions:

• A novel protocol for obtaining human degenerative tenocytes has been successfully developed.
• This protocol facilitates the study of tendinopathy using relevant human pathological cells.
• The characterized degenerative tenocytes show distinct properties, aiding future research into tendinopathy mechanisms and treatments.